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E-mail address: peleg.mor@gmail.com (M. Peleg).Main Clinical Manifestation (MCM)-oriented diagnosis starts with a chief problem and reasons about pos-
sible diagnoses that can be manifested in that way. The reasoning process often starts by considering
abstract diagnosis groups (e.g., infectious vs. non-infectious diarrhea) and reﬁnes them. Most existing
diagnostic decision-support systems (DSSs) are not specially tailored toward assisting non-expert physi-
cians in the proper and efﬁcient investigation workup of MCM-oriented diagnosis. We developed a pro-
totype diagnostic decision-support model called TiMeDDx that is MCM-oriented and follows the
hypothetico-deductive clinical reasoning process of differential diagnosis. The model guides users in a
phase-by-phase manner regarding abstract diagnosis groups and diagnoses that should be considered
and appropriate data that should be collected during the clinical investigation process. TiMeDDx’s knowl-
edge base contains, when possible, knowledge derived from MCM-oriented evidence-based sources. We
explain the knowledge model and diagnostic algorithms (Bayesian and heuristic) of TiMeDDx, using the
clinical problem of diarrhea as a case study, and contrast TiMeDDx with models of existing diagnostic
DSSs.
 2009 Elsevier Inc. All rights reserved.1. Introduction
The diagnosis process is a complex cognitive process compris-
ing a variety of different types of problem solving tasks that are
involved in the clinical reasoning process. In addition, physicians
must follow progress in clinical research and incorporate ever
growing new knowledge regarding diagnosis of clinical problems
and diseases. Clinical Decision Support Systems (DSSs) have been
recognized as important tools to aid clinicians in gathering rele-
vant knowledge and data, making clinical decisions, managing
medical actions more effectively, and thus achieving reduced prac-
tice errors, a higher standard of care, and reduced costs [1]. Clinical
DSSs can provide tools for information management (e.g., retrieval
and storage), for focusing attention (e.g., alerts and reminders), and
for providing patient-speciﬁc recommendations [2]. Diagnostic
DSSs [3] assist a clinician with one or more component steps of
the clinical diagnostic process. Diagnostic DSSs have been devel-
oped since the 1970’s for different ranges of diseases and symp-
toms [4–13]; some systems aim to cover broad medical domains
while other systems focus on speciﬁc problems (e.g., de Dombal’s
DSS for the differential diagnosis of abdominal pain [14]). Asll rights reserved.
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ﬁcult challenges. Despite these challenges, several evaluation stud-
ies have shown diagnostic DSSs to be reliable and accurate
[10,12,15–19]. However, relatively few are being used at present
[7,9–13] and the rate of usage in routine clinical practice is low.
Part of the difﬁculty experienced in incorporating them may be
associated with the lack of integration into the clinical reasoning
process involved in clinical diagnosis.
In essentially all of the diagnostic DSSs, the user enters data
about symptoms, signs, and laboratory test results, and the DSS
produces a list of possible diagnoses, ranked in order of likelihood.
These DSSs help the user in selecting controlled vocabulary terms
to describe the ﬁndings. Some systems [15] guide the user with the
diagnostic process, incorporating rule-in and rule-out diagnostic
processes depending on the scores of the hypotheses in the Differ-
ential-Diagnosis set (DD-set). Other systems [12,13,17] offer deci-
sion-support services that the user can invoke, such as providing a
disease proﬁle, focusing the diagnosis on important features, view-
ing evidence for a diagnosis, and obtaining explanations of ﬁnd-
ings. Most of the existing diagnostic DSSs are used by novice
clinicians, or by experienced clinicians to aid them in diagnosing
difﬁcult cases.
We have noted that the available probabilistic diagnostic DSSs
are not specially tailored toward assisting non-expert physicians
like Primary Care Physicians (PCPs), interns, and residents, in the
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be a symptom, sign, abnormal laboratory or imaging test results, or
a combination of these. We refer to this kind of clinical diagnosis
process as Main Clinical Manifestation (MCM)-oriented diagnosis.
MCM-oriented diagnosis is a problem-oriented process that starts
with a chief clinical problem, reasons about possible diagnoses that
would be manifested as the MCM, and suggests the clinical data
items, laboratory, and imaging tests that should be collected in or-
der to differentiate among alternative diagnoses.
The MCM-oriented reasoning process is often conducted in
phases. At the initial phases, the differential is sometimes between
diagnosis groups that aremeaningful in the context of thediagnostic
process, for example, chronic vs. acute diarrheaor infectiousvs. non-
infectious diarrhea. We refer to such diagnosis groups as abstract
diagnoses. As the diagnostic process advances, the differential is be-
tween actual diagnoses. Such phased problem-oriented process [20]
is preferred for many clinical problems (e.g., syncope, jaundice), as
seen in the classical clinical textbooks and in some speciﬁc medical
books and evidence-based clinical practice guidelines [20,21].
The process of clinical investigation of clinical problems is com-
plex and requires using and analyzing a wide relevant set of clinical
data items in a systematic organizedway. Physicians are expected to
properly handle a wide range of clinical problem investigations. Yet
incompleteworkupwas found to be amajor source of quality of care
problems [22]. DSS can aid physicians tomanage the investigations,
avoidingunnecessary referrals, unnecessary costly tests, or diagnos-
tic errors, by empowering themwith updated knowledge, evidence-
based when possible. Representing and delivering such knowledge
could potentially help overcome diagnostic errors that are due to
cognitive biases, such as ‘conﬁrmation bias’, ‘outcomebias’, or ‘over-
conﬁdence bias’ [23].Motivated by the need for diagnostic DSSs that
would support the investigation process of clinical problems, we
developed a prototype diagnostic system called TiMeDDx — a diag-
nostic decision-supportmodel that isMCM-oriented and supports a
diagnostic process that is conducted inphases of decreasing abstrac-
tion. TiMeDDx is based on an information model that integrates
several newnotions, discussed in Section3,with relational or Bayes-
ian representations used in old diagnostic DSSs (Quick Medical
Reference [16], DXplain [12], and QMR-DT [8]). In Section 2, we dis-
cuss background material related to existing diagnostic DSSs and
MCM-oriented diagnosis. Section 3 introduces the TiMeDDx model
and discusses its knowledge-elicitation process. In Section 4 we
present our preliminary evaluation studies of TiMeDDx, including
its empirical contrast with some of the existing diagnostic DSSs
(QMR, DXplain, and GIDEON). We conclude with a Discussion
followed by a Conclusion section.2. Related work
In this section, we discuss diagnostic DSSs in more detail, focus-
ing on the challenges involved in development of diagnostic DSSs
and comparing existing diagnostic DSSs. We also expand our
discussion on main clinical manifestation-oriented diagnosis and
discuss the hypothetico-deductive clinical reasoning process.
2.1. Challenges in developing diagnostic DSSs
Developing diagnostic DSSs that cover large domains poses
great challenges [3] including:
(1) Acquiring the clinical knowledge and keeping it up to date.
Knowledge can be acquired by eliciting it from domain
experts [24,25] or it can be gathered from the literature or
by compiling data found in electronic medical record sys-
tems [8].(2) Representing and reasoning with the clinical knowledge. The
main decision-support models are quantitative (e.g., statisti-
cal models including Bayesian Networks, machine learning
approaches) or qualitative (e.g., heuristic knowledge repre-
sented as rules, ontologies, or decision tables) [26,27].
(3) Supporting the sequence of reasoning used in the diagnosis
process.
(4) Integrating with controlled vocabularies and clinical infor-
mation systems.
(5) Supporting system evolution, including evaluation, testing,
and quality control.
(6) Addressing legal and ethical issues.
In this paper, we address the ﬁrst three challenges.
2.2. Available diagnostic decision-support systems for broad medical
domains
The ‘‘Leeds abdominal pain system” [14] was the ﬁrst diagnostic
DSS, published in 1972. Since then, a number of computer-based
systems with diagnostic capabilities have been developed for
broad ranges of diseases. Examples include Dxplain [12], Iliad
[10], Meditel [19], Quick Medical Reference (QMR) [6], Problem
Knowledge Coupler (PKC) [13], Isabel [7], Physician Assistant Arti-
ﬁcial Intelligence Reference System (PAIRS) [9] (previously known
as QMR-DT [8]), and Global Infectious Diseases and Epidemiology
Network (GIDEON) [11]. These systems differ in the data used to
determine their probability estimates, the extent to which diseases
and related clinical data are addressed in their knowledge bases,
the particular vocabulary they require to describe clinical data,
and the computational model they use to combine and analyze
data, as shown in Table 1 and described in detail below.
In terms of the computational model, Iliad, Meditel, PAIRS, and
GIDEON are based on Bayes’ theorem; for example, the differential
diagnosis list in GIDEON [11] is based on a Bayesian formula that
compares the mathematical product of disease incidence times
the rate of symptom occurrence for all relevant infectious diseases
within a given country. In addition to using Bayes theorem, Iliad
[10] also uses decision rules for reasoning with clusters of condi-
tionally-independent ﬁndings. This is meant to solve the problem
of over conﬁdent, unreliable diagnostic results that occurred
because ﬁndings were not completely independent.
Isabel [7] uses pattern-matching algorithms to compare ﬁnd-
ings entered by a user to terms used in a selected reference library
that includes text from medical books and journals. By collating
text related to one speciﬁc diagnosis under a single diagnostic label
within a pre-designed diagnostic tree, it was possible for the soft-
ware to generate a unique signature of key concepts for each
diagnosis.
DXplain [12] and QMR [6] (and QMR’s predecessor, Internist-1
[15]) use non-Bayesian algorithms that focus on a relational model
describing relationships between case ﬁndings (symptoms, signs,
laboratory data) and individual diseases to derive a weighted
assessment of a patient’s clinical presentation [17]. In Internist-1
[15] as well as in QMR and DXplain, one type of disease-ﬁnding
relationship represents the frequency with which the ﬁnding oc-
curs in the disease, and the other the degree to which the presence
of the ﬁnding suggests consideration of the disease (evoking
strength). Other tables store the importance of explaining ﬁndings,
disease frequencies (prevalence) and disease importance (impact
of not considering the disease if it is present). The DXplain algo-
rithm also considers the number of diseases in the Differential-
Diagnosis set (DD-set).
Problem Knowledge Coupler (PKC) [13] takes a philosophical
stand that the clinician assessing a patient should understand the
pattern of ﬁndings (and test results) occurring for her patient
Table 1
Characteristics of diagnostic DSSs currently available.
QMR DXplain Iliad GIDEON QMR-DT
(PAIRS)
Isabel Problem knowledge
coupler
TiMeDDx
Sources of knowledge Literature and
experts
Literature
and experts
Literature Literature Literature Literature Literature Literature
and experts
MCM-oriented       + +
Starting point can be a
single clinical data
item
+a +a + + + + + +
DD shown at each
stage
+ + + + + + Can be requested +
Advice on data/tests
that should be
collected
+/ Advice is not
actively offered.
Users can invoke
menu option for
ruling-in and
ruling-out
diagnoses
+ +    Collection of
text material
indexed with
the disease
concepts is
accessible
+ +
Representation of
temporal
relationships
between data items
   +    +
Synergism between
data items
  + + +   +
Consideration of
doctor’s clinical
reasoning, in which
clinical
investigation is
done in stages of
decreasing
abstraction
       +
Local adaptation of
system
 + Some
support
 +   Possible +
Ability of user to
override system
recommendations,
selecting a different
DD-set
+ +     + +
Consideration of all
hypotheses
+ + Rare
disease
displayed
separately
+ + + + Only relevant
diagnoses are listed
Only relevant
diagnoses are
listed
Scope of knowledge Diseases and
ﬁndings for internal
medicine
Diseases and
ﬁndings for
internal
medicine
Diseases and
ﬁndings for
internal
medicine
Diseases
and
ﬁndings
for
Infectious
diseases
Diseases
and
ﬁndings
for
internal
medicine
Diseases and
ﬁndings for
internal
medicine,
pediatrics,
geriatrics
Knowledge relevant
for MCM
Knowledge
relevant for
MCM
Explanations provided + What ﬁndings
support a diagnosis
+ What
ﬁndings
support a
diagnosis
+ +   References to
literature may be
provided
Theoretically-
possible but
not
implemented
Computational model Disease/ﬁnding
Relationships
Disease/
ﬁnding
Relationships
Bayes + decision
rules
Bayes Bayes Pattern-
matching
algorithms
Disease/ﬁnding
relationships;
predecessor/successor
relations between
entities. No ranking of
disease hypotheses
Multi-phase,
anchor based,
relational or
Bayesian
a Focusing the diagnosis on selected ﬁndings is possible.
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ulation. Therefore, the relationships between diseases and ﬁnd-
ings/tests are not weighted and no algorithm is used to rank the
possible diagnoses that explain the ﬁnding; instead, the number
of present ﬁndings associated with each disease hypothesis is
shown next to the disease hypothesis, along with the total number
of ﬁndings which may be associated with that disease, according to
the PKC knowledge base. PKC also allows evaluating the expected
prognosis of a disease with treatment and without treatment. In
addition to the relationships between diseases and ﬁndings, prede-
cessor/successor relationships between entities (diseases or ﬁnd-ings) can ﬂexibly be deﬁned by knowledge modelers to deﬁne
knowledge networks. However, the semantics of the speciﬁc mod-
eler-deﬁned relationships is not formally deﬁned and therefore it
cannot be used to reason in a way that is speciﬁc to the relation-
ship type.
As shown in Table 1, all the diagnostic DSSs that we considered,
except for PKC, focus on broad domains where knowledge regard-
ing the weight of relationships between diseases and ﬁndings do
not depend on the MCM. The knowledge sources for different diag-
nostic DSSs that are in use today come from the literature, but ex-
cept for Isabel, where machine learning algorithms are used to
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from the literature is incorporated into the knowledge base
manually.
All of the diagnostic DSSs can aid a physician during his clinical
reasoning process. They all allow the user to start the diagnosis
process with patient ﬁndings, but out of the systems surveyed in
Table 1, only Iliad, DXplain, and PKC provide advice on data that
should be collected and laboratory tests that should be employed.
In PKC, the sequence of data that should be collected is represented
in the system’s model ahead of time. In all of the diagnostic DSSs,
the DD-set is shown (or can be displayed upon request) at every
stage of the iterative diagnostic process.
GIDEON is the only system that explicitly represents temporal
relationships between data items. All the systems that use a Bayes-
ian computational model can support synergistic effects between
ﬁndings, i.e., ﬁndings that together suggest a diagnosis with a high-
er probability. GIDEON, and to some extent also DXplain, consider
the geographical location of the patient as a factor in the diagnostic
process. When ﬁndings are entered, all possible diagnoses that
cover those ﬁndings are considered in all of the DSS, but disease
prevalence is taken into account for ranking the possible diagnoses.
In DXplain, rare diseases are displayed separately.
The different diagnostic DSSs all provide explanations for why
each of these diseases might be considered. DXplain also lists the
clinical manifestations, if any, which would be unusual or atypical
for each of the speciﬁc diseases and GIDEON also explains why
other diagnoses are not considered. In Isabel, the explanations
are in the form of linking with up to date knowledge from text-
books and journals. However, none of the diagnostic DSSs currently
in use offer pathophysiological reasoning that create models of a
speciﬁc patient’s illness [28–30].
2.3. Hypothetico-deductive reasoning and main clinical
manifestation-oriented diagnosis
Several cognitive models of clinical diagnostic reasoning pro-
cesses have been developed. Some of the highly-accepted models
view the diagnostic process as either hypothesis formulation or
pattern recognition [31]. Our formulation of the clinical problem-
solving process is aligned with the hypothesis-formulation
approach, or hypothetico-deductive reasoning model [32]. Hypoth-
etico-deductive reasoning is an iterative process, which involves
staged data collection followed by data interpretation and the gen-
eration of a set of hypotheses (which in the case of clinical diagno-
sis is known as the DD-set), leading to hypothesis-directed
selection of the next most appropriate data to be collected. The
data collected at each stage are used to reformulate or reﬁne the
active hypotheses. The reasoning process is iterated until one
hypothesis reaches a threshold level of certainty. The staged-pro-
cess helps to focus the reasoning process. When physicians have
collected initial data from the patients’ history and physical exam-
ination, they can generate an initial DD-set. By that time, physi-
cians have expectations of what they will ﬁnd on further
examination or may have speciﬁc tests in mind that will help them
to distinguish among still active hypotheses.
A clinical investigation usually starts from some clinical anchor
ﬁnding. Many times, this clinical anchor is the reason for patients
to seek medical care as well as for physicians to initiate an inves-
tigation. We refer to this as a main clinical manifestation, which
may consist of a single clinical problem such as, diarrhea, syncope,
or jaundice, laboratory test result (e.g., hyponatermia), or combina-
tions of several linked ﬁndings, such as fever and rash (which is a
common clinical manifestation in pediatrics). The MCM plays an
important role in focusing the diagnostic process. This is in concert
with the ﬁndings of Eddy and Clanton [33] who showed that
identiﬁcation of a pivotal ﬁnding is often used to simplify thediagnostic problem and to narrow the focus to a limited set of
hypotheses. During the clinical reasoning process, when doctors
consider the various possible diagnoses that explain the MCM they
take into account the probability of each diagnosis to be mani-
fested as the MCM, ranking diagnoses that are more likely to be
manifested as the MCM higher.
During the diagnostic process, physicians collect and analyze
several types of data types, including subjective information ac-
quired by questioning the patient (i.e., symptoms or medical his-
tory), objective ﬁndings obtained by performing physical
examination (i.e., signs) and all sorts of laboratorial and imaging
data. At any point in this process, there are several diagnoses that
might ﬁt the data collected (i.e., differential diagnosis). Their num-
ber should decrease as the diagnostic process progresses. As has al-
ready been shown years ago, expert clinicians can make a
diagnosis in the majority of patients using the history and physical
examination data alone [34,35].
MCM-oriented diagnosis is a well-accepted approach in clinical
diagnosis. It is evident in medical books [36,37] (e.g., diagnosing
fever and rash in children). Traditionally, text books often did not
report evidence-based statistics regarding disease prevalence per
clinical problem or frequency of clinical data items given a disease.
Medical books based on the principles of evidence-based MCM-ori-
ented diagnosis that report such data are becoming more prevalent
[20]. As our intention was to create a MCM-based diagnostic DSS
that relies on evidence-based clinical knowledge when possible,
we wanted to assess the availability of Evidence-Based (EB)
sources, such as clinical practice guidelines, for aiding MCM-ori-
ented clinical diagnosis utilizing primarily data types found during
history and physical examination. To determine the extent at
which clinical guidelines follow MCM-oriented diagnosis and
report EB statistics, we conducted a study [21] of diagnostic guide-
lines that were archived in the National Guideline Clearinghouse
(NGC) web site (www.ngc.gov) — a public resource for evidence-
based clinical practice guidelines, initiated and maintained by the
Agency for Healthcare Research and Quality and the US Depart-
ment of Health and Human Services. We employed ﬁltering fea-
tures provided by NGC’s website to consider only the potential
diagnostic guidelines (1182 guidelines, at the time of the study).
We then manually inspected each guideline and found that 146
of them indeed addressed diagnosis that starts with a MCM. After
characterizing 25% of these guidelines [21], we found little use of
quantitative statistical data, such as frequency of manifestation
of ﬁndings in given diseases and disease prevalence, for determin-
ing diagnosis. That trend found in the study [21], which was done
in 2007, was also observed in an updated study that we are cur-
rently summarizing. In addition, we found that many of the guide-
lines make use of disease categories i.e., abstract diagnoses rather
than just individual diagnoses. Some guidelines reported temporal
and synergistic relationships between patient ﬁndings, which
serve as important knowledge for diagnosis.
These ﬁndings suggest that although MCM-oriented diagnosis is
a well accepted diagnostic approach, MCM-oriented guidelines
that report evidence-based statistical data are not very common,
necessitating the elicitation of such data from other sources, such
as experts or from statistical clinical databases.3. TiMeDDx
We developed a prototype diagnostic DSS called TiMeDDx to
assist physicians in the process of MCM-oriented diagnosis. TiMe-
DDx emphasizes proper workup of a presenting symptom, sign,
abnormal test result or a combination of these and supports a
hypothetico-deductive diagnostic process. Toward this goal, TiMe-
DDx integrates several notions in a novel way resulting in a multi-
Y. Denekamp, M. Peleg / Journal of Biomedical Informatics 43 (2010) 111–124 115phase, anchor-based information model that uses abstract diagno-
sis groups. This multi-phase approach, which revolves upon an an-
chor ﬁnding per each phase, enables efﬁciency in conducting the
diagnostic process using a minimal effective set of Clinical Data
Items (CDIs) in each phase. In Section 3.1 we explain the notions
of the MCM-oriented approach of TiMeDDx. Section 3.2 details
how we integrated these notions and structured them in the infor-
mation model of TiMeDDx. Sections 3.3 and 3.4 discuss two possi-
ble computational models for scoring disease hypotheses, which
can be used with TiMeDDx’ information model. Finally, Section
3.5 discusses the development process of a TiMeDDx knowledge
base.
3.1. The notions used in TiMeDDx’ MCM-oriented approach
TiMeDDx’s MCM-oriented approach uses the following six
notions.
3.1.1. MCM-oriented diagnosis
TiMeDDx enables MCM-oriented diagnosis and emphasizes the
use of clinical data items from the history and physical examina-
tion; a MCM is any CDI or a combination of CDIs that can be a
symptom, sign, laboratory or other test, which is the starting point
of the diagnosis process. MCM-orientation was ﬁrst introduced in
the Present Illness program [39] and in Problem Knowledge Cou-
pler [13]. Unlike other DSSs, in TiMeDDx the MCM is treated as
being more important than other ﬁndings and plays a crucial role
at focusing the diagnostic process. TiMeDDx does not associate
every disease with every ﬁnding, as done in diagnostic DSS for
broad domains, nor does it represent its knowledge as a network
of interconnected frames of diseases and clinical states from which
disease hypotheses are selected, based on ﬁndings exhibited by the
patient, as done in the Present Illness program. TiMeDDx considers
and ranks for each MCM only the set of diagnoses whose main clin-
ical manifestation is the MCM, as reported in EB sources or medical
literature that discuss problem-oriented diagnosis. This is expected
to enable more efﬁciency and accuracy in scoring the different
diagnosis hypotheses that are evoked by the MCM. For example,
if the MCM is hyponatremia (low level of sodium), then in TiMe-
DDx, pneumonia will not be part of the DD-set as it is in some
other models. This is because although hyponateremia can be
found in pneumonia, it will never be the main clinical manifesta-
tion of pneumonia; a patient with pneumonia will exhibit other
ﬁndings (e.g., fever, cough, rapid breathing, etc.) that will focus
the clinician on pneumonia.
3.1.2. Phases
TiMeDDx is novel in supporting a diagnostic process that is car-
ried out in predetermined phases. TiMeDDx supports phases by
structuring the process of DD reduction as a predetermined tree
of hierarchical DDs, which we refer to as DD-tree. Each layer of
the tree corresponds to a diagnostic phase (e.g., acute diarrhea,
infectious diarrhea), mimicking the clinician’s hypothetico-deduc-
tive reasoning process of diagnosis that is used during problem-
oriented diagnosis. At the beginning of the diagnostic process,
the focus (anchor) of the diagnosis is the MCM (e.g., diarrhea, jaun-
dice, syncope) that triggered the diagnostic process, and serves as
the root of the tree. For this anchor, a set of diagnoses that can be
abstract and relevant clinical data items for making a diagnosis are
deﬁned. As shown in Table 2a for the diarrhea anchor, a set of two
abstract diagnoses are provided in phase 1: acute vs. chronic diar-
rhea. To differentiate between them, TiMeDDx uses the CDIs:
‘‘duration of diarrhea 614 days” and ‘‘duration >14 days”, which,
per deﬁnition, are considered pathognomonic (i.e., unambiguously
characteristic of a particular disease) for discriminating between
these two alternatives. As the diagnostic process advances throughthe levels of the diagnostic tree, the DD-set becomes more and
more speciﬁc. For example, if in phase 1, the selected alternative
was acute diarrhea, then, as shown in Table 2b, acute diarrhea
serves as the anchor for phase 2. Phase 2 includes ﬁve alternatives,
including infectious diarrhea, medication change, inﬂammatory
bowel disease, intermittent bowel obstruction, and colonic ische-
mia. To differentiate among these hypotheses TiMeDDx uses a col-
lection of CDIs that are relevant for that phase, as shown in the
second row of Table 2b and the user enters values to indicate
whether these CDIs are present in the patient. The strengths/prob-
abilities of relationships between disease hypotheses and CDIs in
each phase are indicated as numbers in the table, as explained later
in this section. Based on the CDIs values for the patient, an algo-
rithm (heuristic or Bayesian) ranks the diseases in the DD-set
and sets the highest ranking disease as the new anchor for the next
phase.
3.1.3. Abstractions
As explained above, the multi-phase diagnostic process of TiMe-
DDx often starts with abstract concepts, is reﬁned in each phase,
and ends in speciﬁc diagnoses. This diagnostic process that uses
abstractions is valuable not only because of the efﬁciency of CDIs
considered in each phase, but also because abstractions are often
used by clinical experts during problem-solving. As discussed by
Newell and Simon [38], studies examining constrained problem
spaces such as chess-playing have documented that experts recog-
nize patterns of activity within a domain at an integrated, higher
level (‘‘chunking”) than novices. Abstractions have been used in
diagnostic DSSs before. Abstractions have been used in the Inter-
nist-1 [30] knowledge base, which contains a hierarchy of disease
categories, organized primarily around the concept of organ sys-
tems, where positive ﬁndings can evoke either individual disease
nodes or higher-level nodes in the disease hierarchy. Pople [30]
suggested a reasoning model where any given disease can be clas-
siﬁed in as many descriptive categories of the hierarchy as are
appropriate.
3.1.4. Anchor-speciﬁc disease-ﬁnding relationships
TiMeDDx provides weighted relationships between disease and
ﬁndings that are speciﬁc to the given anchor and to a given geo-
graphical location, including (a) the DD-set that is relevant and
probable for the given MCM (ﬁrst column in Table 2); (b) the set
of relevant ﬁndings that can distinguish among the diagnoses in
the DD-set (the top row in each table of the Table 2 table set).
While these two relationships are present in PKC, in PKC, they
are not weighted; (c) the likelihood of a diagnosis to be manifested
as the anchor (second column in Table 2) — a notion that is unique
to TiMeDDx. This is used to rank higher diagnoses that are usually
manifested as the anchor ﬁnding. For instance, for an anchor of
syncope, the DD-set includes cardiac arrhythmias and pulmonary
embolism, yet cardiac arrhythmias are more likely to be mani-
fested as syncope than pulmonary embolism; (d) the evoking
strength with which a ﬁnding suggests a diagnosis in the DD-set
(numbers in the cells of Table 2). Unlike the use of this feature in
Internist-1 [15] (where it was ﬁrst introduced), QMR, DXplain,
and the Present Illness program, the evoking strength in TiMeDDx
considers just the disease hypotheses that are relevant for the an-
chor ﬁnding (which, at the beginning of the process is the MCM);
(e) the penalty that a disease hypothesis should receive in the
absence of a ﬁnding (numbers given in parentheses in the cells
of Table 2). Penalties are also used in other diagnostic DSSs, such
as Internist-1 [15] (where they were ﬁrst introduced), QMR,
DXplain, and the Present Illness program. However, in TiMeDDx,
the size of this penalty is proportional to the frequency at which
the disease exhibits the ﬁnding; and (f) synergistic effect between
ﬁndings that together suggest a diagnosis with greater certainty
Table 2
A set of three tables showing a path in the DD-tree. Each table represents a different layer (phase) in the tree. The second column shows the disease manifested as anchor
relationship data. The other cells in the tables show evoking strengths and penalties (penalties are shown in parentheses) for diagnoses given an anchor. The anchor is diarrhea in
phase 1, acute diarrhea in phase 2, and infectious diarrhea in phase 3. The numbers in table (b) were elicited from experts and the numbers from tables (a) and (c) were elicited
from EB sources.
(a) Phase 1 anchor: diarrhea
Diagnosis Dx manifested as diarrhea CDI
Duration <14 days Duration >14 days
Acute diarrhea Pathognomonic
Chronic diarrhea Pathognomonic
(b) Phase 2 anchor: acute diarrhea
Diagnosis Dx manifested as
acute diarrhea
CDI
High
fever
Abrupt
presentation
Nausea/
vomiting
Mucus Arthritis More people
developed
Infectious diarrhea 16 9 9 8 1 9
Medication change 8 7 3
Inﬂammatory bowel disease 14 4 2 2 8 9 (5)
Intermittent bowel obstruction 10 2 2
Colonic ischemia 8 2 2
(c) Phase 3 anchor: infectious diarrhea
Diagnosis Manifested as infectious diarrhea CDI
Fever Abdominal
pain
Tenesmus Nausea/
vomit
Watery
diarrhea
Flu-like
symptom
Bloody
stools
Recent
antibiotic
Shigella 8 (7) 8 7 (7) 8 4
Non-Shigella bacterial 7 (5) 7 4 3
Clostridium 3 2 8 (6)
Parasitic 1 3
Food-bornea 0
Viral 8 2 8 9 7 (8)
a Disease-ﬁnding relationships for the food-borne diagnosis are provided in Table 3.
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tionships may be temporal (e.g., fever before rash, Jaundice after
fever) or not temporal, just two ﬁndings that together strengthen
a diagnosis.
3.1.5. Computational model
TiMeDDx’ information model can be combined with different
computational models (a heuristic model and a Bayesian model)
for scoring disease hypotheses. This feature was guided by the
Bayesian formulation [8] of the heuristic algorithm of QMR [6].
Uniquely, in TiMeDDx the Bayesian formulation is structured
according to the phases of anchors used in the MCM-oriented diag-
nostic process. The last three relationships between disease and
ﬁndings discussed above are used with the heuristic scoring algo-
rithm, discussed in Section 3.4. The Bayesian approach, discussed
in Section 3.3, uses prior probabilities for each disease hypothesis
and conditional probabilities for each combination of ﬁnding and
disease (ﬁnding frequencies).
3.1.6. User control
TiMeDDx’ philosophy allows the user to follow the diagnostic
process with any diagnosis in the DD-set, even if it is not the high-
est-ranking one. This feature, which also exists in PKC, is in accor-
dance with the modern view of DSSs [40] as providing assistance to
a user who is in charge of the clinical process rather than being a
Greek oracle who solves the clinical task for the user. This property
is important because, as pointed out by Miller [41], no computerTable 3
A table for eliciting synergistic temporal relationships between CDIs and diagnoses, for th
Diagnosis CDI-1 CDI-2
Food-borne diarrhea Time of onset of diarrhea Time of ingestionprogram can know all that needs to be known about the patient
case, no matter howmuch time or effort is spent on data input into
the computer system, and therefore the clinician user who directly
evaluated the patient must be considered to be the deﬁnitive
source of information about the patient during the entire course
of any computer-based consultation.3.2. The TiMeDDx information model
The main class in the TiMeDDx model is Anchor, which repre-
sents the MCM in the ﬁrst phase of the diagnostic process. Anchor
is deﬁned using three structural slots and three relationship slots.
The relationship slots store knowledge that is used by the TiMe-
DDx algorithm to score diagnoses in the DD-set. Fig. 1 shows an in-
stance of the Anchor class, as modeled using the Protege-2000 [42]
modeling tool.3.2.1. Structural slots
anchor_concepts— the concept (or concept combination, such as
fever and rash) on which the DD is focused at the current diagnosis
phase. In Fig. 1, the anchor concept is Acute Diarrhea.relevant_diag-
noses_or_abstractions — the relevant diagnoses for the current DD
phase. At initial DD phases, we often use abstractions instead of
ﬁnal diagnoses.relevant_CDIs — the CDIs that should be collected
in order to select the most probable diagnosis from the DD-set.
For each CDI we specify the medical concept and whether it is ae anchor of infectious diarrhea.
Time between two CDIs Weight (penalty)
of suspicious food 0–6 h 10 (9)
Fig. 1. An instance of the Anchor class.
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anchor, as shown in Fig. 2.
3.2.2. Relationship slots
The following types of relationships relate CDIs to diagnoses.
They are used by the algorithm that scores the diagnoses in the
DD-set. Fig. 3 shows the information model of these three relation-
ships, using an Entity-Relationship (ER) Diagram [43] — where
each information class is represented by an entity type (depicted
as a rectangle) and relationships between information classes are
represented by a relationship type (depicted as a diamond). We
use the ER notation because it is widely familiar and simple and of-
ten is used to represent information models.
diagnoses_manifested_as_anchor — bonus points are given to
diagnoses that are usually manifested as the anchor concept1(s).
For example, cardiac arrhythmias are often manifested as syncope
(anchor), but pulmonary embolism, which is in the DD-set of the
syncope anchor, is usually not manifested as syncope.
CDI_evokes_Diagnosis — Like the Internist-1/QMR system [15],
TiMeDDx considers CDIs that suggest a diagnosis, with a certain
evoking strength (1–10). As in Internist-1, frequency_penalty
stores the frequency at which a ﬁnding is found in a disease; when
the patient does not exhibit a CDI that is frequent in a disease
hypothesis, points can be deducted from that hypothesis.
Synergistic_CDI_Relationship_Given_Diagnosis_For_Anchor — in
some cases, when combinations of two (or more) CDIs occur to-1 Often, the anchor concept holds a MCM that is a patient’s CDI. However, the
anchor may alternatively be an abstraction used in the DD (part of the DD-set), such
as in the case of infectious diarrhea, which is an abstract anchor concept and not the
MCM (the MCM is diarrhea).gether or in a certain temporal pattern, this suggests a certain diag-
nosis more probable than the additive contribution of each one of
the CDIs alone. For example, if it is known that diarrhea developed
less than 6 h after ingesting suspicious food, it suggests the diagno-
sis of toxin-borne diarrhea, based on the combination of the diar-
rhea and ingestion of suspicious food as CDIs, as shown in Fig. 4.3.3. A Bayesian model for scoring disease hypotheses
We have attempted to reformulate TiMeDDx model in Bayesian
terms with certain simplifying assumptions. As was done for the
Bayesian formulation of the QMR knowledge base [8], we assumed
that ﬁndings are conditionally independent given any disease
hypothesis (therefore the probability of having multiple ﬁndings
given a hypothesis is the product of probability of having one ﬁnd-
ing given the hypothesis, for all ﬁndings in the set of ﬁndings).
Therefore, we convert temporal synergistic relationships between
two ﬁndings and a disease hypothesis into one ﬁnding. As in
QMR-DT, we model the inﬂuence of multiple diseases on a ﬁnding
assuming causal independence (i.e., the probability of a ﬁnding gi-
ven only one disease is present P(F|D) instead of given combina-
tions of diseases. In this way, all the conditional probabilities
that we use in the Bayesian Networks (BNs) are of the form
P(F|D), representing frequency data. We also assume that only
one of the alternative hypotheses would be present in a patient.
To take advantage of the phased model of TiMeDDx, we arrange
the knowledge in sets of small BNs, where each network corre-
sponds to one phase of TiMeDDx’s Knowledge-Base (KB) and in-
cludes the relevant ﬁndings and disease hypotheses for that
phase, the prior probabilities of the disease hypotheses and the
Fig. 3. An Entity-Relationship Diagram showing the information model of the three relationships used to deﬁne an Anchor. Concepts are shown as rectangles and
relationships as diamonds. Multi-cardinality relationships are marked with n, m, p, and r. For example, (a) represents the following statement: ‘‘Anchor is manifested as n
(many) Diagnoses or Abstractions”. Properties of relationships are written below the diamond symbols. Examples of entity relationships instances are provided in
parentheses. The arrows mark the directionality in which the relationship should be read. (a) Diagnosis_Manifested_ As_Anchor — the example shows that a diagnosis of
Hepatitis B is manifested as jaundice with a probability of 17 (out of 20); (b) CDI_Evokes_Diagnosis_In_Anchor — the CDI fever with a value of high or low, in an anchor of
infectious diarrhea evokes the diagnosis Bacterial (non-Shigella) diarrhea with an evoking strength of 7 (out of 10) and a frequency_penalty of 5; (c) Temporal_CDI_Rela-
tionship_Given_Diagnosis_For_Anchor — If the time of ingesting suspicious food is 3 ± 3 h before the time of onset of diarrhea, in an anchor of Infectious Diarrhea, the
diagnosis of toxin-borne diarrhea is evoked with weight of 10 (out of 10) and 9 points are penalized from that diagnosis hypothesis for the absence of ingestion of suspicious
food (frequency_penalty).
Fig. 2. Speciﬁcation of an anchor: fever. Fever is a required CDI for the anchor of acute diarrhea, which is collected during the physical exam. The insert on the right shows the
allowed value type of this CDI: temperature. Temperature is an instance of Categorical_Value. The categories of temperature are low or high.
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that correspond to the example discussed in Section 3.1.Because the TiMeDDxmodel is arranged in diagnostic phases, as
we move from a BN of one phase to the BN of the next phase, we
Y. Denekamp, M. Peleg / Journal of Biomedical Informatics 43 (2010) 111–124 119simply reﬁne our diagnosis without the need to combine the
numerical results from previous phases. For example, in phase 1,
setting the value of duration to 614 and updating the model will
result in a posterior probability of 1 for acute diarrhea. Given that
abstract diagnosis, we proceed to the phase 2 BN whose anchor is
acute diarrhea.
To distinguish the main clinical manifestation from other man-
ifestations of a disease, we use the information contained in the
disease_manifested_as_anchor relationships of TiMeDDx to update
the values of the posterior probabilities of the disease hypotheses.
To do so, we construct another BN consisting of the diseases (or
abstractions) used in the DD-set of a phase and the phase’s anchor
(see Fig. 7 b). The probabilities used in this network would be the
prior probabilities of the diseases. The conditional probabilities
relating the anchor to the individual disease hypotheses P(an-
chor|D) are derived from the disease_manifested_as_anchor rela-
tionships. From this small network, we can derive the posterior
probability for a disease hypothesis given that the anchor is pres-
ent. These probabilities can now serve as the prior probabilities
for the diseases in the BN composed of the diseases in the DD-set
for the phase and all the other ﬁndings apart from the MCM
(Fig. 7c).
Using the above Bayesian approach requires having prior prob-
abilities for each disease hypothesis and conditional probabilities
for each combination of ﬁnding and disease (ﬁnding frequencies).
In QMR-DT, the prior probabilities were assembled from data
compiled by the National Center for Health Statistics on inpatients
discharged from short-stay nonfederal hospitals and the condi-Fig. 4. Deﬁnition of a temporal synergistic relationship between a pair of CDIs that evokes
whose range is 1–10. The ﬁgure shows that when the anchor is infections diarrhea, then
suggests, with weight 10, the diagnosis of toxin-borne diarrhea. But, when ingestion of su
of toxin-borne diarrhea.tional probabilities P(F|D) were derived from the QMR frequency
data. We tried to base our data on EB studies. However, as ex-
plained in Section 3.5, many of the required statistical values are
not found in the EB sources. Therefore, for simplicity of implemen-
tation, we chose a heuristic approach for scoring diagnoses that re-
quires eliciting fewer probabilities from experts, eliminating the
need to specify all prior probabilities of diseases and conditional
probabilities of ﬁnding given disease. This approach is described
next.
3.4. TiMeDDx’ diagnosis-scoring algorithm
The heuristic scoring algorithm of TiMeDDx requires the input
of fewer probabilities than the Bayesian methods discussed in
the previous subsection. The algorithm, shown in Fig. 5, considers
CDIs that suggest a diagnosis with a certain evoking strength. If the
CDI is present, then points are awarded according to the evoking
strength. If the CDI is considered to be pathogneumonic in evoking
the diagnosis, as is sometimes the case for laboratory or imaging
ﬁndings and very rarely for history and physical examination ﬁnd-
ings, then that diagnosis would be concluded. If, however, the CDI
is not present penalty can be used to deduct points for certain dis-
ease hypotheses. The size of the frequency_penalty indicates the
likelihood of a hypothesis being inappropriate when a certain
CDI is absent.
The last component used for scoring diagnoses is Synergis-
tic_CDI_Relationship_Given_ Diagnosis_For_Anchor. When such a
relationship is deﬁned and both CDIs are present, points are addeda diagnosis in a given anchor. The evoking strength is speciﬁed by the slot ‘‘weight”,
the occurrence of ingestion of speciﬁc food 3 h (±3 h) before the onset of diarrhea
spicious food is not present in the patient, 9 points are penalized from the diagnosis
For a given anchor, 
For each possible diagnosis Dxi calculate the following score: 
 + (0..20) points if DXi is manifested as the anchor 
 For each CDIj for which (CDIj-evokes-Dxi) exists: 
  If the patient exhibits the CDI and the CDI is pathogneumonic,  
exit the algorithm, setting Dxi as the only Dxi that should be considered  
+evokes (0..10) of CDI if the patient exhibits the CDI 
  -penalty (0..10) of CDI if the patient does not exhibit the CDI  
 For pairs of CDIs that have synergistic effects (CDI Relationship) 
  +weight (0..10) if both CDIs are present in the patient 
  -penalty (0..10) if not both CDIs are present in the patient 
Fig. 5. The diagnoses scoring algorithm.
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relationship. If not both CDIs are present, we use selective penalty
to deduct points from the diagnosis.
After all the diagnoses in the DD-set were scored, we calculate
the cutoff — diagnoses that are below the cutoff will not continue
to future steps of the algorithm. The cutoff is calculated as a value
that is 10% lower than the score of the highest ranking diagnosis.
The algorithm will suggest the diagnoses that are above the cutoff.
If a disease hypothesis was selected via a pathogneumonic ﬁnding,
then no cutoff value is necessary — only that hypothesis is sug-
gested. However, the user may choose to override the recom-
mended diagnosis and select a different diagnosis from the DD-
set for the current anchor. The system can then set this diagnosis
as the anchor for the next diagnosis phase, taking the information
for the appropriate phase from the respective node in the DD-tree.
We do not allow the user to jump to any node in the DD-tree; if the
user has already reached a certain anchor we interpret it to mean
that he has accepted all the abstractions leading to that node. If this
is not the case, the user can start another session.
Fig. 6 provides an example of one phase of the algorithm, based
on the knowledge shown in Fig. 1. That knowledge was adapted
from a medical book based on the principles of evidence-based
MCM-oriented diagnosis [20] and from the infectious diarrhea
guideline [44], as explained in the next subsection. The full run
of the algorithm can be found in Appendix A. The patient for which
the algorithm was executed has been having high fever for 7 days,
nausea, vomiting, bloody stools, abdominal pain, and tenesmus.
The symptoms appeared abruptly and we do not know whether
other people had the disease. However, we know that the following
ﬁndings are not present: ingestion of suspicious food, mucus, anti-
biotics, ﬂu-like symptoms, and arthritis.Infectious Diarrhea  16+9+8+8 =41
Medication Change   8+7+3 =18 
Inflammatory Bowl Disease 14+4+2+2-5 =17 
Intermittent Bowel Obstruction  10+2+2 =14 
Colonic Ischemia   8+2+2 =12 
Cuttoff = 41 – (0.1*41) = 36.9 
Fig. 6. The scores of the hypotheses deﬁned in the DD-set of the current phase of
the algorithm, shown in Fig. 1. Numbers appearing in italics (the ﬁrst number in
each row) are based on the Diagnosis_manifested_as_anchor relationship. Numbers
appearing in regular font are based on the CDI_evokes_Diagnosis relationships
(evoking strengths and penalties). The scores of the Dxs that are above the cutoff
are shown in bold.Examining the score of the ﬁrst diagnosis, Infectious Diarrhea,
we can see that 16 points (out of 20) were awarded based on the
fact that this diagnosis is usually manifested as diarrhea (the an-
chor), and 9, 8, and 8 points (out of 10 maximum points per ﬁnd-
ing) were awarded based on the CDI_evokes_diagnosis links
between this diagnosis and the following CDIs: fever (high), abrupt
presentation, and nausea/vomiting. Note that the relationship of
arthritis evokes inﬂammatory bowel disease with a fre-
quency_penalty of 5 was used to deduct points from that disease
hypothesis because arthritis was not present.
3.5. Developing a TiMeDDx knowledge base
In the TiMeDDx approach, which is centered on a MCM, the set
of disease hypotheses and CDIs considered at each diagnosis phase
as well as the relationships between ﬁndings and disease hypoth-
eses depend on the MCM. Therefore, knowledge added to the TiMe-
DDx knowledge base to support diagnosis of a new MCM is
independent of the knowledge that already exists in the knowledge
base for existing MCMs. This has several consequences. First,
phase-speciﬁc knowledge usually cannot be reused for different
MCMs. For example, while arrhythmias are considered as disease
hypothesis for a syncope MCM and for a palpitations MCM, differ-
ent arrhythmias are considered for each MCM, and with different
likelihoods. However, as we advance toward more speciﬁc phases
in a DD-tree (e.g., bradyarrhythmia), it is more likely that these
phases could be reused for the DD-trees of different MCMs. A sec-
ond consequence of the independence of MCM-oriented diagnostic
knowledge is that the addition of knowledge for a new MCM will
not affect system performance, because only the DD-tree for that
MCM would need to be considered. A third consequence is that
the process of developing the TiMeDDx knowledge for different
MCMs can be done independently and in parallel. In the rest of this
section we discuss the steps involved in developing the TiMeDDx
knowledge needed to support diagnosis of a MCM, addressing
the level of effort needed. This is based on our experience in devel-
oping the knowledge for the diarrhea MCM and for our ongoing
development of the syncope MCM. Whenever possible, we tried
to elicit disease hypotheses, relevant CDIs, evoking strengths, fre-
quencies of manifestations, weights of diagnosis manifested as an-
chor, and weights of synergistic relationships based on EB studies.
The disease hypotheses that we considered for the diarrhea case
and the CDIs used to distinguish between them were based on
EB sources [20,44]; Table 2 shows the disease hypotheses (ﬁrst col-
umn) that we considered and the CDIs (top row) used to differen-
tiate among them.
Some EB studies report probabilities of manifestation of a ﬁnd-
ing given a disease (frequency). In TiMeDDx, the important prob-
abilities for the heuristic algorithm are the evoking strengths, i.e.,
the probabilities of disease given a ﬁnding P(D|F) for a given
anchor. However, these probabilities are usually not available in
evidence-based studies. Bayes law can be used to convert the fre-
quency data into P(D|F) based on the prior probabilities of dis-
eases and of ﬁndings per a given anchor. However, the prior
probabilities of a ﬁnding (per anchor) are difﬁcult to ﬁnd, and
the prevalence of common etiologies of diarrhea in a primary care
setting is reported to be unknown in the EB source that we used
[20, p. 282]. Nevertheless, since for a given anchor, a small set of
relevant diagnoses (or abstract diagnosis groups) are considered
as the DD-set, we used the frequency numbers P(F|D) to select
the most relevant diagnosis in the limited DD-set, assuming uni-
form prior probabilities of diseases (prevalence). In this way, the
disease in which the CDIs exhibited by the patient are most fre-
quent is the disease that should be evoked. We converted the fre-
quency numbers to a scale of 0–10. When ranges were reported,
we used the average. Frequency data were provided in the clinical
acute
chronic
Dx acute chronic
less14
over14
Dx
Duration
?
?
(a)
Dx
Acute diarrhea 
anchor
?
?
(b)
infectious
medication
IBD
intemittent
ischemia
Dx infectious medication IBD intermittent ischemia
yes
no
(c)
infectious
medication
(d)
Dx
High 
fever
?
? ? ? ? ?
More 
people?
Abrupt Nausea Mucus Arthritis
IBD
intemittent
ischemia
Acute Sub Type infectious medication IBD intermittent ischemia
yes 0.725 0.5 0.6 0.5 0.5
no 0.275 0.5 0.5 0.5
Infection 
Type
Fever
?
? ? ? ? ? ?
Tenesmus Nausea Watery Flu 
symptoms
?
Bloody 
stools
Abdominal 
pain
?
Antibiotics
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Fig. 7. Bayesian Networks (BN) for the three phases of diagnosis of diarrhea derived from the knowledge represented in Table 2 with uniform prior probabilities of disease
hypotheses. (a) Phase 1 BN. The top insert shows the prior probability of the two abstractions: acute and chronic diarrhea. The uniform prior probabilities are shown for
illustrative purposes. The bottom insert shows the conditional probabilities of P(F|D); (b) BN for computing prior probabilities of disease hypotheses of phase 2 BN, relying on
the ‘‘diagnosis manifested as anchor” relationships of Table 2(b); (c) BN corresponding to phase 2. The prior probabilities are those derived by computing the posterior
probability based on the BN shown in (b). The conditional probabilities for P(high fever|D) are shown for illustrative purposes; (d) BN corresponding to phase 3. The BN were
created using the GeNIe tool (http://genie.sis.pitt.edu/) and reproduced in the ﬁgure.
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the infectious diarrhea abstraction (Fig. 2c). Evoking strength data
for the non-infectious acute diarrhea (Fig. 2b) were supplied by
our experts.
In order to determine the frequency_penalty which we use to
subtract points in a selective way from a hypothesis when the pa-
tient does not exhibit a ﬁnding that is manifested in high frequency
in a disease, we relied on judgment of two clinical experts, who
consulted the frequency values reported in the EB studies, but used
their expert opinion to decide about the selective penalty (see
Section 3.4). These experts also provided numbers for other
relationships for which no data were reported in the EB studies:
the synergistic effects (scale of 1–10) and Diagnosis_Mani-
fested_As_Anchor (scale of 1–20) in the context of diarrhea.
To elicit from experts the frequencies, penalties, and weights for
diagnosis manifested as anchor for our preliminary study, we pre-
pared Excel tables such as those shown in Tables 2 and 3. The
structure of the tables was set based on evidence-based sources
and the numbers were supplied by two experts by consensus
formulation.
When eliciting such data from experts for amore comprehensive
evaluation study, we suggest following themethodology for knowl-edge base construction based on expert opinion that was proposed
by van Ast et al [25]. That methodology suggests starting with a
group of experts and calculating the inter-rater interclass correla-
tion coefﬁcient; if it is not large enough, the Spearman–Brown
prophecy can be used to predict the number of additional experts.
The effort required to develop the TiMeDDx knowledge for a gi-
ven MCM is considerable. Based on our experience, gathering infor-
mation from evidence-based sources and arranging it in phases of
disease hypotheses and CDIs used to distinguish among them re-
quired less effort than acquiring the numbers (which include fre-
quencies, penalties, and weights for diagnosis manifested as
anchor) that were not available in the EB studies. Working with
the experts requires several iterations; in the ﬁrst iteration, which
spans several sessions, the experts supply all the requestednumbers
using the tables that we prepared. Then a statistical examination of
expert agreement is conducted to see if the numbers could be aver-
aged. As noted above, establishing agreement between experts may
require using additional experts. After agreement is established the
numbers are entered into the knowledge base and the system’s per-
formance on test cases is evaluated, as described in the next section.
Fine tuning the knowledgebase to support the initial set of test cases
requires further iterations with the experts.
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We tested and reﬁned the TiMeDDx model by examining the
MCM-oriented diagnostic process of diarrhea. As EB sources of
medical knowledge, we used a medical book of problem-oriented
diagnosis [20] and a guideline [44] for diagnosing infectious diar-
rhea. Screenshots from the TiMeDDx model of that guideline were
presented in Section 3. We validated our encoding using the diar-
rhea test case. An example of the TiMeDDx heuristic algorithm run
on the diarrhea test case is provided in Appendix A. We used 8 case
vignettes to develop and ﬁne-tune the diarrhea knowledge base
and 10 additional test cases to validate it, using the heuristic algo-
rithm. All the test cases are presented in Appendix B. The test cases
and two of the training set cases were developed by a clinician who
was not involved in the development of TiMeDDx and had no
knowledge of it. TiMeDDx produced the expected results for all
the test cases. In one test case, TiMeDDx could not differentiate be-
tween two diagnoses. The higher-ranking diagnosis (Bacterial diar-
rhea, non-Shigella) was the correct one, but it received a score that
was just one point higher than the diagnosis of Shigellosis. How-
ever, even experts ﬁnd it hard to differentiate these two diagnoses
from the presenting clinical data items.
When designing a more comprehensive evaluation study, we
intend to train the system with about ﬁve patient cases for each
diagnosis and to test it with ﬁve test cases for each diagnosis.
The patient cases should have different characteristics and should
be prepared by 2–3 clinicians who are not the developers of the KB.
As was done in [45], we plan to use real patient cases as an addi-
tional evaluation.
We executed the same test case shown in Appendix A on several
diagnostic DSS for broad domains: QMR, DXplain, and GIDEON. Our
aim was to see how probabilistic diagnostic DSSs for broad do-
mains perform in supporting the process of an investigation of a
clinical problem (e.g., diarrhea). If they would perform well in
MCM-oriented diagnosis — a task for which they were not de-
signed — there would not be a need for special-purpose diagnostic
DSSs, such as TiMeDDx. The results are shown in Appendices C, D,
and E, respectively. As can be seen, entering a single clinical man-
ifestation (acute diarrhea into QMR and bloody diarrhea into
DXplain) produced a DD-set that does not use abstractions but
contains concrete diagnoses. In the DD-set, the correct diagnosis
(Shigellosis) was not one of the top diagnoses (above 35%) in
QMR. In DXplain, it was the fourth diagnosis in the rare disease list.
QMR does not guide the user as to what additional data should be
collected to distinguish among diagnoses, so we entered the case
ﬁndings unaided, to reﬁne the DD-set. Once again, Shigellosis
was not the top scoring diagnosis. Moreover, the ﬁrst score in
QMR, toxin-borne diarrhea, ranked extremely low in TiMeDDx (be-
cause it is known that the patient did not ingest suspicious food)
and was eliminated by it. Similar results were obtained with
DXplain. Although DXplain asked the user about additional ﬁnd-
ings that may be present, most of them were not relevant to differ-
entiate Shigellosis from the other diagnoses in the DD-set. This
strengthens the advantage of TiMeDDx in supporting efﬁcient
investigations of clinical problems.
Running the diarrhea case in GIDEON produced better results
than the QMR and DXplain runs. Upon entering the single problem
‘‘diarrhea”, the correct diagnosis (Shigellosis) was ranked ﬁrst.
Note that, GIDEON normally prompts the user to input a few other
parameters (not just one ﬁnding): disease onset time and geo-
graphical location. Entering the case’s values for these parameters
changed the DD; Shigellosis was no longer the top diagnosis. GID-
EON did not guide us as to what other ﬁnding we should be looking
for. After entering the other ﬁndings in the test case, GIDEON cor-
rectly identiﬁed Shigellosis as the top diagnosis, well separating itfrom the other diagnoses in the DD-set. However, GIDEON contains
knowledge just for infectious diseases. Thus, naturally, GIDEON
will not help in diagnosing inﬂammatory (non infections) or med-
ication-change related diarrhea.
5. Discussion
Several diagnostic DSSs have already established themselves as
valuable instruments for supporting clinicians in diagnosis of
broad areas of medicine [7,9,10,12,13,16,19] and infectious dis-
eases [11]. We focused on a niche that has been much less ad-
dressed — decision-support for MCM-oriented diagnosis meant to
support non-expert physicians in the process of investigating clin-
ical problems in all ﬁelds of medicine. We present TiMedDDx — a
novel model for multi-phase MCM-oriented anchor based diagno-
sis that is conducted in phases of decreasing abstraction — and its
preliminary evaluation. The information model of TiMeDDx allows
it to center the diagnostic process around an anchor ﬁnding, con-
sidering all diseases that may be manifested as the MCM. Unlike
other approaches that are not based on a MCM and try to relate
all ﬁndings to all diagnoses, TiMeDDx considers only diagnoses
that are manifested as the anchor, enabling an efﬁcient way of
managing the diagnostic process.
In an early paper [29], Szolovits et al. suggested that any diagnos-
tic DSS should have amodel of disease and an algorithm performing
clinical reasoning. Such an algorithm has the following properties,
also observed in TiMeDDx: (1) it matches what is known about the
patientwith representeddiagnostic knowledge; (2) it directs elicita-
tion of useful information about additional ﬁndings that may be
present; (3) it limits the number of hypotheses considered and per-
forms sophisticated evaluation of a small number of hypotheses; (4)
it narrows the focus of the diagnostic process using abstractions of
disease hierarchies; and (5) it concludes the most probable diagno-
sis. Unlike the reasoning process described in [29], TiMeDDx does
not have a causal diseasemodel that supports pathophysiologic rea-
soning, like all other models discussed.
TiMeDDx leverages the work done in early diagnostic DSSs,
such as QMR and DXplain, utilizing relationships between diseases
and ﬁndings that indicate evoking strength (used to reward points
for diseases that explain ﬁndings present) and frequency_penalty
(used to penalize a disease for ﬁndings absent). However, unlike
earlier systems, TiMeDDx’ heuristic algorithm does not penalize
disease hypotheses for ﬁndings present that are not explained by
the disease (ﬁnding_importance, used in Internist-1 [15]); since
the set of disease hypotheses per anchor is relatively small, such
penalty need not be used in order to differentiate between the dis-
ease hypotheses per a given anchor. Since ﬁnding importance is
not used in TiMeDDx its heuristic algorithm uses fewer variables
to compute the score for each disease. While this saves effort in
eliciting the knowledge, the ability to ﬁne-tune the knowledge is
restricted, and therefore the knowledge base needs to be validated
carefully to conﬁrm that the correct decision-support is provided
for different patient cases.
Any diagnostic DSS needs to contain knowledge about relation-
ships of ﬁndings and diseases. The difﬁculties of eliciting probabil-
ities of manifestation from the literature and from experts makes it
extremely hard to gather and maintain massive databases of prob-
abilities that copes with all possible interactions [29]. This task is
much smaller in TiMeDDx, for which the interactions considered
are for a given MCM, and not for any possible ﬁnding and disease.
The probability elicitation task is even more limited because mod-
eling a MCM-oriented diagnostic process in TiMeDDx considers
only the ﬁndings and diagnoses that are relevant for a particular
anchor. Our Bayesian formulation of the phased anchor-oriented
diagnostic process aligned the Bayesian model with hypothetico-
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tions of diseases and ﬁndings for which probabilities should be de-
ﬁned. However, the number of required probabilities was still high.
Such probabilistic data are rarely supplied by EB studies or diag-
nostic clinical guidelines and it is difﬁcult to extract such data from
experts. Therefore we utilized a heuristic scoring algorithm that re-
quires eliciting fewer numbers. After training, that algorithm per-
formed very well on the test cases of the preliminary evaluation.
To elicit data about probabilities of manifestations of ﬁndings in
diseases, which is required to formulate the TiMeDDx knowledge
base, we wanted to rely on numbers reported in EB studies. How-
ever, such data was not always available. When it was, we often
found that EB studies reported a large range of probabilities. For
example, the diarrhea guideline [44] reports that 48–100% of pa-
tients infected by Campylobacter species exhibit bloody stools,
based on two studies that produced very different frequencies.
To determine a number to use for TiMeDDx, we simply took the
average, although averaging is problematic in cases where the
numbers do not agree. In that case, there is an advantage of having
local adaptation features in TiMeDDx; the probabilities differ
according to geographical and even institutional factors.
For some of the manifestation probabilities and synergistic ef-
fects no numbers were provided in EB studies. Therefore, we had
to rely on experts’ judgment. It is possible that themulti-phasemod-
el of TiMeDDx that uses abstractions may facilitate knowledge
extraction from clinician experts. It has been demonstrated that ex-
pert problem-solving techniques rely on using appropriate abstrac-
tions [46] and that their reasoning processes depend on making
distinctions between cases that they encounter (e.g., patients pre-
senting with MCMs) and classiﬁcation of such cases [47], as in the
diagnosis process supported by TiMeDDx. Expert knowledge acqui-
sition tools focusing on the problem-solvingmethod have been suc-
cessfully used in a variety of real-world applications [48]. While
some studies point out that humans do not always provide accurate
sources of probabilistic information [49], it has been shown that hu-
manexperts canprovide reliable information about the frequencyof
occurrence of manifestations given a disease [24]. After eliciting the
knowledge for thediarrheaMCMandvalidating the resultingknowl-
edge base, we used the diarrhea test case to contrast TiMeDDxwith
different probabilistic diagnostic DSSs, starting with diarrhea as a
single ﬁnding. Our results showed that TiMeDDx produced very
good results in the preliminary evaluation, identifying the correct
diagnosis. QMR and DXplain contained the correct diagnosis in the
DD-set of the rare diseases when a more reﬁned MCM was entered
(bloody diarrhea or acute diarrhea rather than diarrhea), and
DXplain’s suggestion about further relevant ﬁndings did not im-
prove the diagnosis (QMR does not make such suggestions). On the
other hand, the GIDEON, which was speciﬁcally built for infectious
diseases, DSS included the correct diagnosis as the top-most diagno-
sis in the DD-set even when diarrhea was the only ﬁnding entered.
Although we cannot draw conclusions based on this preliminary
comparison, it illustrates the differences in the decision-support be-
tween a DSSwhose aim is to suggest all possible diagnoses in which
someof the patientﬁndings are present, and rank them inorder of ﬁt
with the patient’s ﬁndings, and a DSS whose aim is to support the
clinical investigation of a clinical problem. The test case’s execution
in thedifferent systemspoints to thevalueof a system, suchasTiMe-
DDx for supporting the investigation workup of clinical problems.
5.1. Limitations and future work
A limitation of our study is that TiMeDDx has not yet been eval-
uated in practice. The potential success of TiMeDDx depends on its
performance as well as on the possibility of eliciting the knowledge
required to build a useful knowledge base. So far, only preliminary
evaluation has been carried out. We are currently conducting anelaborate study to evaluate the TiMeDDx model with the test case
of syncope as a MCM. In this study we are eliciting the medical
knowledge from expert cardiologists in Israel.
TiMeDDx follows a problem-oriented diagnostic process that is
often used by physicians.
However, a second limitation is that it is possible to use TiMe-
DDx only for diagnosing the MCMs contained in its knowledge
base. This is in contrast to other diagnostic DSSs that associate
ﬁndings and diseases regardless of an MCM, thus enabling the
use of their knowledge for a diagnostic process that is not neces-
sarily based on a deﬁned set of MCMs.
Another limitation is that while TiMeDDx’ model ﬁts many clin-
ical problems, such as syncope or diarrhea, for which there is prac-
tically one explanation, the model might be inappropriate for a
problem like anemia in an elderly patient, where more than one
explanation may exist.
A further limitation is that in case the clinician observed several
ﬁndings in her patient (e.g., fever, cough, rapid breathing, hypona-
tremia) and chose as the anchor a ﬁnding that is not the most
important one (e.g., hyponatremia), then the system will not help
her in reaching the correct diagnosis (e.g., pneumonia). However,
we assume that clinicians are skilled in selecting the appropriate
anchor, which can be a ﬁnding or a combination of ﬁndings.
The diagnostic process supported by TiMeDDx works in phases,
where a minimal effective set of clinical data items (CDIs) is con-
sidered in each phase; not all the CDIs for all phases of the diagnos-
tic process are considered at once. If the knowledge base is built in
a hierarchically-correct way, then each ﬁnal diagnosis would be-
long to an abstraction that ﬁts with the data collected at the initial
phase. The knowledge base should be tested to validate this. Difﬁ-
cult cases may occur if the score of two abstractions is not very far
apart (yet the higher-scoring abstraction is separated from the next
one by over 10%).
TiMeDDx is still under development. Our future plans are to
combine principles learned from the GLIF3 guideline modeling lan-
guage [50]. While GLIF3 is not a highly suitable model for diagno-
sis, as its model is deterministic and does not reason under
uncertainty, as done in probabilistic models, we may still leverage
from it. As in GLIF3, we would like to use controlled vocabularies to
specify clinical terms (ﬁndings, diseases) and to incorporate a pa-
tient information model, enabling retrieval of data from electronic
medical records.
Since we are aware of the complexity that sometimes exists in
real-world diagnosis, we would like to develop a user-interface
that would enable the user to select any diagnosis/abstraction in
the current DD-set and continue with it even if it is not the one that
has the highest calculated probability, based on the knowledge in
the TiMeDDx knowledge base.
Finally, TiMeDDx can potentially be relevant for other domains,
such as business process management. Diagnostic business pro-
cesses, such as trouble shooting and ‘helpdesk’ functionality start
with a main presenting problem (e.g., some computer failure man-
ifestation), span several phases of diagnosis that start from abstract
to speciﬁc, and include instructions about eliciting symptoms from
the customers presenting with the problem. Such translation from
a clinical to a non-clinical domain was made by the developers of
the MOLE [5] system, who used their system to elicit expert knowl-
edge and develop a DSS in domains such as clinical diagnosis and
diagnosis of car problems. We plan to research the applicability
of TiMeDDx to the business domain.
6. Conclusion
TiMeDDx is a prototype diagnostic system that is MCM-ori-
ented, supports a diagnostic process that is conducted in phases
of decreasing abstraction, and follows the staged reasoning process
124 Y. Denekamp, M. Peleg / Journal of Biomedical Informatics 43 (2010) 111–124of differential diagnosis, guiding the user in a phase-by-phase
manner regarding data that should be collected during the clinical
investigation process. Due to the new notions modeled in TiMe-
DDx, and the encouraging preliminary evaluation results, we be-
lieve that there is a justiﬁcation to examine the model further in
the domains of clinical as well as non-clinical diagnosis.Acknowledgments
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